HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK ad authority on J&J ad

This article was originally published in The Rose Sheet

Executive Summary

A print advertisement for Johnson & Johnson's RoC CompleteLift Face Cream in the UK must not appear again in its current form, according to the UK's Advertising Standards Authority, an independent organization created by the UK advertising industry to monitor ads. ASA reviewed the ad following two complaints regarding claims, including "Measurable lift in just 8 weeks," "clinically proven to work in just 8 weeks of use," "clinically proven to work" and one that the product contains a patented ingredient that "retightens and firms the facial contours by contracting skin cells." J&J defended its claims, stating they were substantiated by a clinical study confirmed by consumer perception data. However, ASA concluded the evidence from the clinical study did not support the efficacy of the product, so the claims are misleading to consumers

You may also be interested in...



Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015680

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel